Orthogonal, Inc.
Orthogonal, Inc., is developing environmentally safe, high-performance fluorinated photoresists to make “organic,” or carbon-based electronics on the same machinery manufacturers use to make silicon-based electronics.
IntElect Medical, Inc.
IntElect Medical, Inc., develops and commercializes neurostimulation systems for improving the recovery of brain injury patients. Intelect Medical was acquired by Boston Scientific Neuromodulation Corporation in 2011. IntElect Medical, Inc., was acquired by the Boston Scientific Corporation in 2011.
Medeor, Inc.
Medeor, Inc., develops d-methadone, a novel nonopioid analgesic. Medeor was acquired by Relmada Therapeutics, Inc. in 2013.
MiTeGen, LLC
MiTeGen, LLC, designs and manufactures products for X-ray diffraction and crystallography of proteins and small molecule/inorganic compounds, and for manipulation and measurement of small samples in cell biology, histology, clinical diagnostics, entomology, archaeology, and geology.
Novomer, Inc.
Novomer, Inc., is a sustainable chemistry company pioneering a family of high-performance, environmentally responsible polymers and chemical intermediates.
OptiGen, LLC
OptiGen, LLC, provides DNA-based diagnoses and information about inherited diseases of dogs. OptiGen was acquired by Mars Petcare in 2018.
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc., is a clinical stage, biopharmaceutical company developing novel mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal and metabolic diseases. The company’s first clinical candidate, Bendaviaâ„¢, targets the mitochondria to treat cardio-renal and microvascular impairments.
Phytex, LLC
Phytex, LLC, produces phytase enzymes for an animal feed product called OptiPhos. This product enables poultry and pigs to absorb more phosphorus from their feed grain, creating substantially less phosphorus in their waste. Phytex was acquired by Huvepharma in 2013.
GeneWeave Biosciences, Inc.
GeneWeave Biosciences, Inc., is a medical diagnostics company focused on infectious diseases. GeneWeave was acquired by Roche Holding AG in 2015.
Acuamark Diagnostics, Inc.
Acuamark Diagnostics is developing novel diagnostic tests to enable low-cost and accurate early detection of colorectal cancer directly from the blood, by isolating and identifying multiple cancer markers. Thus, allowing for improved sensitivity, specificity, and scalability.
